Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,076.00
(
-0.49%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
99.04
(
2.39%
)
Bitcoin
77,769.11
(
-0.60%
)
News Focus
News Focus
Post# of 20777
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Dubb10

Send PM Follow Ignore
Followers 34
Posts 1982
Boards Moderated 0
Alias Born 01/25/2010

Dubb10

Re: Jumpinjackas post# 19784

Saturday, 04/09/2016 3:36:20 PM

Saturday, April 09, 2016 3:36:20 PM

Post# of 20777
I can believe that. I tried to contact them last week and didn't hear a peep.

I'm in the camp that believes if Shire didn't want to continue, they would've made it known by now. As of Dec 2015, SHP622 was still listed on their slate for FA (financials and main website). However, it's still not listed on their clinical trials summary site. No updates on the main clinical trials site either.

Might be a case where big corporate red tape is an issue. Shire now has 60 development programs in their pipeline. They're a big company, but that is still a lot to have to manage.

My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today